Related Experiment Video
Updated: Feb 26, 2026
04:24
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
12.7K
Social Media Platforms and Heart Failure
R Jay Widmer1, Makala K Arce2, Lee A Aase2
1Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
Journal of Cardiac Failure
|July 18, 2017
Summary
Social media platforms like Facebook and YouTube show potential for improving heart failure (HF) patient care. Further research is needed to confirm these benefits and ensure safe patient engagement.
Area of Science:
- Cardiology
- Digital Health
- Health Informatics
Background:
- The increasing prevalence of internet and social media use necessitates exploring their application in patient care.
- Patient engagement strategies for heart failure (HF) often overlook digital platforms.
Purpose of the Study:
- To investigate the potential utility of social media platforms for patients with heart failure.
- To analyze early findings and Mayo Clinic's experience with social media in healthcare.
Main Methods:
- Review of general social media usage patterns.
- Analysis of enterprise-wide social media data.
- Examination of heart failure-specific social media content and engagement.
Main Results:
- Facebook and YouTube emerge as potentially beneficial platforms for heart failure patients.
- Social media data, including HF-related content, suggests platform-specific advantages.
Conclusions:
- Social media, particularly Facebook and YouTube, may offer benefits for heart failure patient engagement.
- Prospective, large-scale studies are required to validate these findings and establish safe engagement protocols for HF care.
Related Concept Videos
01:27Heart Failure I: Introduction
1.0K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.0K
01:17Pathophysiology of Heart Failure
4.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K
01:29Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
476
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
476
01:22Heart Failure Drugs: β-Blockers
1.0K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.0K
01:26Heart Failure III: Clinical Manifestations
716
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
716